Similar articles

• Immunologic features of genitourinary cancer.

  Javadpour N. Javadpour N. Urology. 1973 Aug;2(2):103-8. doi: 10.1016/0090-4295(73)90239-2. Urology. 1973. PMID: 4129366 Review. No abstract available.
• Immunology of genitourinary tumors.

  Guinan P, Sadoughi N, Bush IM, John T, Eghrari F, Ablin RJ. Guinan P, et al. Urology. 1973 Nov;2(5):493-9. doi: 10.1016/0090-4295(73)90554-2. Urology. 1973. PMID: 4131868 Review. No abstract available.
• Abnormalities of cell-mediated immunocompetence in genitourinary cancer.

  Catalona WJ, Chretien PB, Trahan EE. Catalona WJ, et al. J Urol. 1974 Feb;111(2):229-32. doi: 10.1016/s0022-5347(17)59935-8. J Urol. 1974. PMID: 4855735 No abstract available.
• Lymphocyte antibody interaction in cytotoxicity against human transitional cell carcinoma.

  Hakala TR, Lange PH, Castro AE, Elliott AY, Fraley EE. Hakala TR, et al. J Urol. 1975 May;113(5):663-7. doi: 10.1016/s0022-5347(17)59548-8. J Urol. 1975. PMID: 1168732
• Carcinoembryonic antigen and urothelial carcinoma.

  Hall RR, Laurence DJ, Neville AM, Wallace DM. Hall RR, et al. Br J Urol. 1973 Feb;45(1):88-92. Br J Urol. 1973. PMID: 4690154 No abstract available.